WO2001010841A3 - Fluorene derivatives as integrin inhibitors - Google Patents
Fluorene derivatives as integrin inhibitors Download PDFInfo
- Publication number
- WO2001010841A3 WO2001010841A3 PCT/EP2000/007153 EP0007153W WO0110841A3 WO 2001010841 A3 WO2001010841 A3 WO 2001010841A3 EP 0007153 W EP0007153 W EP 0007153W WO 0110841 A3 WO0110841 A3 WO 0110841A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- integrin inhibitors
- fluorene derivatives
- disorders
- arteriosclerosis
- thrombosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/44—Nitrogen atoms not forming part of a nitro radical
- C07D233/48—Nitrogen atoms not forming part of a nitro radical with acyclic hydrocarbon or substituted acyclic hydrocarbon radicals, attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
- C07C279/12—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0202464A HUP0202464A3 (en) | 1999-08-07 | 2000-07-26 | Imidazolyl aminoalkyl fluorene derivatives, process for their preparation, pharmaceutical compositions containing them and their use |
JP2001515308A JP2003506439A (en) | 1999-08-07 | 2000-07-26 | Fluorene derivative |
SK140-2002A SK1402002A3 (en) | 1999-08-07 | 2000-07-26 | Fluorene derivative, process for the preparation thereof and pharmaceutical composition comprising same |
MXPA02001297A MXPA02001297A (en) | 1999-08-07 | 2000-07-26 | Fluorene derivatives. |
CA002380981A CA2380981A1 (en) | 1999-08-07 | 2000-07-26 | Fluorene derivatives |
BR0013083-4A BR0013083A (en) | 1999-08-07 | 2000-07-26 | Fluorane Derivatives |
AU68286/00A AU6828600A (en) | 1999-08-07 | 2000-07-26 | Fluorene derivatives |
PL00353054A PL353054A1 (en) | 1999-08-07 | 2000-07-26 | Fluorene derivatives as integrin inhibitors |
EP00956284A EP1208088A2 (en) | 1999-08-07 | 2000-07-26 | Fluorene derivatives as integrin inhibitors |
KR1020027000660A KR20020012631A (en) | 1999-08-07 | 2000-07-26 | Fluorene derivatives |
NO20020592A NO20020592L (en) | 1999-08-07 | 2002-02-06 | Fluorine derivatives as integrin inhibitors |
HK03101305.5A HK1049006A1 (en) | 1999-08-07 | 2003-02-20 | Fluorene derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19937394A DE19937394A1 (en) | 1999-08-07 | 1999-08-07 | Fluorene derivatives |
DE19937394.9 | 1999-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001010841A2 WO2001010841A2 (en) | 2001-02-15 |
WO2001010841A3 true WO2001010841A3 (en) | 2001-09-07 |
Family
ID=7917613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/007153 WO2001010841A2 (en) | 1999-08-07 | 2000-07-26 | Fluorene derivatives as integrin inhibitors |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1208088A2 (en) |
JP (1) | JP2003506439A (en) |
KR (1) | KR20020012631A (en) |
CN (1) | CN1368962A (en) |
AR (1) | AR025042A1 (en) |
AU (1) | AU6828600A (en) |
BR (1) | BR0013083A (en) |
CA (1) | CA2380981A1 (en) |
CZ (1) | CZ2002298A3 (en) |
DE (1) | DE19937394A1 (en) |
HK (1) | HK1049006A1 (en) |
HU (1) | HUP0202464A3 (en) |
MX (1) | MXPA02001297A (en) |
NO (1) | NO20020592L (en) |
PL (1) | PL353054A1 (en) |
SK (1) | SK1402002A3 (en) |
WO (1) | WO2001010841A2 (en) |
ZA (1) | ZA200201873B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101102808B1 (en) * | 2010-04-13 | 2012-01-05 | 윤태삼 | Riser tensioner |
US8574899B2 (en) | 2010-12-22 | 2013-11-05 | Vladimir B Serikov | Methods for augmentation collection of placental hematopoietic stem cells and uses thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015602A1 (en) * | 1989-06-22 | 1990-12-27 | Nova Pharmaceutical Corporation | Pharmaceutical compositions and methods for treating inflammation |
EP0675112A1 (en) * | 1994-03-31 | 1995-10-04 | Bristol-Myers Squibb Company | Imidazole-containing inhibitors of farnesyl protein transferase |
WO1997036862A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
DE19654483A1 (en) * | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanine derivatives |
EP0832883A1 (en) * | 1996-09-26 | 1998-04-01 | Eli Lilly And Company | Tetrahydrobenzo(a)fluorene compounds and methods of use |
-
1999
- 1999-08-07 DE DE19937394A patent/DE19937394A1/en not_active Withdrawn
-
2000
- 2000-07-26 MX MXPA02001297A patent/MXPA02001297A/en not_active Application Discontinuation
- 2000-07-26 BR BR0013083-4A patent/BR0013083A/en not_active Application Discontinuation
- 2000-07-26 AU AU68286/00A patent/AU6828600A/en not_active Abandoned
- 2000-07-26 HU HU0202464A patent/HUP0202464A3/en unknown
- 2000-07-26 SK SK140-2002A patent/SK1402002A3/en unknown
- 2000-07-26 KR KR1020027000660A patent/KR20020012631A/en not_active Application Discontinuation
- 2000-07-26 CA CA002380981A patent/CA2380981A1/en not_active Abandoned
- 2000-07-26 PL PL00353054A patent/PL353054A1/en unknown
- 2000-07-26 WO PCT/EP2000/007153 patent/WO2001010841A2/en not_active Application Discontinuation
- 2000-07-26 EP EP00956284A patent/EP1208088A2/en not_active Withdrawn
- 2000-07-26 CN CN00811476A patent/CN1368962A/en active Pending
- 2000-07-26 JP JP2001515308A patent/JP2003506439A/en active Pending
- 2000-07-26 CZ CZ2002298A patent/CZ2002298A3/en unknown
- 2000-08-04 AR ARP000104035A patent/AR025042A1/en unknown
-
2002
- 2002-02-06 NO NO20020592A patent/NO20020592L/en not_active Application Discontinuation
- 2002-03-06 ZA ZA200201873A patent/ZA200201873B/en unknown
-
2003
- 2003-02-20 HK HK03101305.5A patent/HK1049006A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990015602A1 (en) * | 1989-06-22 | 1990-12-27 | Nova Pharmaceutical Corporation | Pharmaceutical compositions and methods for treating inflammation |
EP0675112A1 (en) * | 1994-03-31 | 1995-10-04 | Bristol-Myers Squibb Company | Imidazole-containing inhibitors of farnesyl protein transferase |
WO1997036862A1 (en) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
DE19654483A1 (en) * | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanine derivatives |
EP0832883A1 (en) * | 1996-09-26 | 1998-04-01 | Eli Lilly And Company | Tetrahydrobenzo(a)fluorene compounds and methods of use |
Also Published As
Publication number | Publication date |
---|---|
ZA200201873B (en) | 2003-08-27 |
KR20020012631A (en) | 2002-02-16 |
BR0013083A (en) | 2002-04-23 |
AU6828600A (en) | 2001-03-05 |
WO2001010841A2 (en) | 2001-02-15 |
EP1208088A2 (en) | 2002-05-29 |
HUP0202464A3 (en) | 2003-02-28 |
JP2003506439A (en) | 2003-02-18 |
NO20020592D0 (en) | 2002-02-06 |
CA2380981A1 (en) | 2001-02-15 |
SK1402002A3 (en) | 2002-06-04 |
AR025042A1 (en) | 2002-11-06 |
DE19937394A1 (en) | 2001-02-08 |
MXPA02001297A (en) | 2004-07-16 |
HUP0202464A2 (en) | 2002-12-28 |
PL353054A1 (en) | 2003-10-06 |
NO20020592L (en) | 2002-04-04 |
CZ2002298A3 (en) | 2002-04-17 |
CN1368962A (en) | 2002-09-11 |
HK1049006A1 (en) | 2003-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW372232B (en) | Phenylalanine derivatives | |
NO20010203L (en) | Diacylhydrazine derivatives as integrin inhibitors | |
NO986090L (en) | Phenylalanine derivatives as integrin inhibitors | |
NZ511927A (en) | Phenylglycine derivatives | |
MY134783A (en) | Rho-kinase inhibitors | |
MY142915A (en) | Rho-kinase inhibitors | |
WO2002057261A3 (en) | Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase | |
CA2280727A1 (en) | Bicyclic amino acids | |
DE60324183D1 (en) | Aryl-, aryloxy- und alkyloxysubstituierte 1h-indol-3-yl-glyoxylsäurederivateals inhibitoren des plasminogenaktivatorinhibitors-1 (pai-1) | |
NO972892L (en) | Bicyclic Low Molecular Weight Thrombin Inhibitors | |
WO2001064642A3 (en) | Benzamides and related inhibitors of factor xa | |
TW200407326A (en) | Pyrimido compounds having antiproliferative activity | |
WO2000055159A3 (en) | Substituted aza-oxindole derivatives | |
CA2348391A1 (en) | Chromenone and chromanone derivatives as integrin inhibitors | |
WO2001035950A3 (en) | Benzamide therapeutics and methods for treating inflammatory bowel disease | |
WO2000021910A3 (en) | 1,2-disubstituted cyclopropanes | |
WO2000071516A3 (en) | INHIBITORS OF FACTOR Xa | |
AR027398A1 (en) | DERIVATIVES OF INDOL-3-ILO | |
WO2002018379A3 (en) | 7-oxo pyridopyrimidines | |
WO2000048996A3 (en) | β-ALANINE DERIVATIVES | |
NO308897B1 (en) | Benzothiazine dioxides as endothelin antagonists, processes for their preparation, pharmaceutical compositions comprising the compounds, and use of the compounds | |
ATE311389T1 (en) | PRECURSOR OF IMIDAZOPYRIDINE DERIVATIVES | |
NZ240481A (en) | Aminosulphonyl urea derivatives and pharmaceutical compositions | |
NO20032754D0 (en) | Urea and / or urethane derivatives as integrin inhibitors | |
NO20020131L (en) | Diacylhydrazinderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000956284 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027000660 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2002-298 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1402002 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2380981 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/001297 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008114765 Country of ref document: CN Ref document number: 10049053 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027000660 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 68286/00 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2002/301/KOL Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2002 2002105512 Country of ref document: RU Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200200222 Country of ref document: VN |
|
WWP | Wipo information: published in national office |
Ref document number: PV2002-298 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 2000956284 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2002-298 Country of ref document: CZ |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000956284 Country of ref document: EP |